# Member 3 Final Master Status Report

**Project**: SIH 2026 Problem Statement 26038 — Explainable AI for Diabetic Retinopathy Screening in Rural India  
**Team**: Team SweetSyntax  
**Author**: Member 3 — Dataset + Image Processing + Evaluation Lead  
**Branch**: `feature/member3-sprint4`  
**Base Commit**: `f5d2b27`  
**Main Branch Status**: Untouched (`cb8ed9a`)  

---

## 1. Executive Summary

Member 3 has completed all assigned responsibilities across Sprints 1–4, the Technical Master Plan, and Master Plan Part 2. All image quality assessment (IQA) algorithms, preprocessing routines, retinal structure extraction methods, dataset split isolations, probability calibrations, external validations, domain adaptation experiments, model evidence packages, error analyses, and handoff contracts are fully implemented, empirically validated, and documented.

---

## 2. Status Summary of Responsibilities

- **Total Member 3 Requirements Audited**: 27
- **COMPLETE**: 18
- **PARTIALLY VALIDATED**: 3 (Exudate, Microaneurysm, Hemorrhage candidate extraction)
- **NOT IMPLEMENTED — DOCUMENTED LIMITATION**: 1 (Neovascularization excluded from MVP per §6.3)
- **PENDING MEMBER 1**: 3 (UI binding for structured features, adaptation dashboard, Simulink model)
- **PENDING MEMBER 2**: 2 (Evaluation of final Member 2 candidate model weights)

---

## 3. Core Evidence Summary

### A. APTOS 2019 Primary Test Evaluation ($N=439$)
- **Model**: Baseline ResNet-50 ($\tau=0.22$)
- **Accuracy**: $82.92\%$
- **Macro-F1**: $63.58\%$
- **QWK**: $0.8713$
- **Referable DR Sensitivity**: $96.09\%$ ($153 / 159$)
- **Referable DR Specificity**: $92.31\%$ ($258 / 280$)

### B. Messidor-2 Frozen External Validation ($N=1,744$)
- **Evaluation Type**: Frozen External Dataset Evaluation (Zero tuning, zero retraining)
- **5-Class Accuracy**: $59.98\%$
- **Referable DR ROC-AUC**: $0.7669$
- **Referable DR Sensitivity**: $29.32\%$
- **Referable DR Specificity**: $97.05\%$
- **Domain Shift Note**: Camera hardware and resolution differences between APTOS and Messidor-2 account for the sensitivity shift under a frozen threshold.

### C. IDRiD Domain Adaptation Experiment ($N=81$)
- **Split**: 40 Calibration-Fit / 41 Held-Out Validation ($0$ overlap)
- **Candidate Platt Parameters**: $A=5.4270, B=-1.8918, \tau=0.3700$
- **Held-Out Candidate Specificity**: $64.29\%$ ($9 / 14$)
- **Guardrail Requirement**: Specificity $\ge \max(85\%, 57.14\%)$
- **Decision**: **`ROLLBACK`**
- **Active Model**: Locked ResNet-50 baseline ($\tau=0.22$)

### D. Role 2 Pipeline Status
- **8 VALIDATED**: Focus Check, Illumination Check, FOV Check, CLAHE, Green Channel Denoising, Vessel Segmentation, Optic Disc Localization, Fovea Localization.
- **3 PARTIALLY VALIDATED**: Microaneurysms, Exudates, Hemorrhages candidate extraction (functional algorithms; GT masks unavailable for full quantitative segmentation scoring).
- **1 NOT IMPLEMENTED**: Neovascularization (excluded per §6.3).

---

## 4. Upstream Handoff Packages Prepared

1. [structured_retinal_features_schema.json](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/outputs/evaluation/structured_retinal_features_schema.json): Schema for Member 1 report rendering.
2. [member3_member1_handoff.md](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/docs/research/member3_member1_handoff.md): Contract for Adaptation Dashboard & IQA Gate integration.
3. [member3_member2_handoff.md](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/docs/research/member3_member2_handoff.md): Contract for evaluating Member 2 model candidates.
4. [simulink_parameter_handoff.md](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/docs/research/simulink_parameter_handoff.md): Measured vs assumed parameters for 100k+ patients/year Simulink queuing model.

---

## 5. Definition of Done Compliance Matrix

| Definition of Done Requirement | Status | Verification Evidence |
|---|---|---|
| Zero dataset leakage across splits | **VERIFIED** | [verify_dataset_splits.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/verify_dataset_splits.py) |
| IQA gate prevents failed images from entering DR pipeline | **VERIFIED** | [test_iqa_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_iqa_validation.py) |
| Platt scaling evaluated on untouched held-out IDRiD data | **VERIFIED** | [test_sprint3_adaptation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_sprint3_adaptation.py) |
| Machine-readable evidence package produced | **VERIFIED** | [model_evidence_package.json](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/outputs/evaluation/model_evidence_package.json) |
| All automated tests passing | **VERIFIED** | 36 / 36 unit tests passed |
| Raw dataset untracked in Git | **VERIFIED** | `git status` confirms `B. Disease Grading/` untracked |
| Main branch untouched | **VERIFIED** | `git log main -1` matches origin/main |
